Scholars Central

Conference abstractPublished 17 Sep 2018

Roles of nanomedicine in clinical neuroscience

Authors: Alain L Fymat

Institute of Medicine and Science, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

One of the most promising applications of nanomedicine principles is in clinical neuroscience, particularly in the treatment of glioblastomas and neurological disorders (epilepsy, Parkinson's disease; Alzheimer's disease, etc.). Here, speciallydesigned nanoparticles (NPs) delivered by specially-designed nanocarriers are able to cross the blood brain barrier to deliver their payload at pre-defined location(s) according to specified time- and dose-fractionations while remaining unnoticed by the immune system. I will discuss the several NPs utilized and their corresponding clinical advantages, including: nutshells (that can be targeted to bond to cancerous cells by conjugated antibodies or peptides to anopheles' surfaces); platelet-coated NPs (that can deliver higher doses of medication drugs to targeted sites, thus greatly enhancing their therapeutic effects); biocompatible and biodegradable gelatin NPs (that can deliver multiple drugs); and shape-shifting engineered NPs (that can can be tailored to deliver drugs to specified tumors and nowhere else).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Pharmaceutical Care & Health Systems.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmaceutical Care & Health Systems
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Alain L Fymat”